Artículos

***Si sabes de algún artículo de acceso libre relacionado con las diversas áreas de la Rehabilitación Cardiovascular envía la referencia para agregarlo a los siguientes correos electrónicos: prevencioncardiovascular@gmail.com y/o ibarra.miguel@ciprecar.org .

Dieta

Intervención de educación para la salud en enfermedades cardiovasculares en el Centro Penitenciario de Soria (03/2016). Referencia: Martínez-Delgado MM, Ramírez-López C. (2016). Intervención de educación para la salud en enfermedades cardiovasculares en el Centro Penitenciario de Soria. Revista Española de Sanidad Penitenciaria, 18 (1), 5-11.

Randomised controlled pilot study to assess the feasibility of a Mediterranean Portfolio dietary intervention for cardiovascular risk reduction in HIV dyslipidaemia: a study protocol (02/2016). Referencia: Stradling C, Thomas GN, Hemming K, et al. Randomised controlled pilot study to assess the feasibility of a Mediterranean Portfolio dietary intervention for cardiovascular risk reduction in HIV dyslipidaemia: a study protocol. BMJ Open 2016; 6: e010821. doi: 10.1136/bmjopen-2015-010821.

CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial (01/2016). Referencia: Corella D,  Asensio EM, Coltell O, et al. CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial. Cardiovascular Diabetology 2016; 15:4. DOI 10.1186/s12933-015-0327-8.

Low Salt Diet and Insulin Resistance (01/2016). Referencia: Oh H, et al. Low Salt Diet and Insulin Resistance. Clinical Nutrition Research 2016;5:1-6. doi:  10.7762/cnr.2016.5.1.1.

Greater Total Antioxidant Capacity from Diet and Supplements Is Associated with a Less Atherogenic Blood Profile in U.S. Adults (01/2016). Referencia: Kim K, Vance TM, Chun OK. Greater Total Antioxidant Capacity from Diet and Supplements Is Associated with a Less Atherogenic Blood Profile in U.S. Adults. Nutrients 2016; 8:15; doi:10.3390/nu8010015. 

Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet (12/2015). Referencia:  Lepore SM, Morittu VM, Celano M, et al. Oral Administration of Oleuropein and Its Semisynthetic Peracetylated Derivative Prevents Hepatic Steatosis, Hyperinsulinemia, and Weight Gain in Mice Fed with High Fat Cafeteria Diet. International Journal of Endocrinology 2015; 2015: 431453. http://dx.doi.org/10.1155/2015/431453.

Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis (11/2015). Referencia: van der Heijden RA, Bijzet J, Meijers WC, et al. Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Scientific Reports 2015; 5: 16474. From PMC: doi:  10.1038/srep16474.

Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study (12/2014). Referencia:Wu JH, Lemaitre RN, King IB, et al. Circulating Omega-6 Polyunsaturated Fatty Acids and Total and Cause-Specific Mortality: The Cardiovascular Health Study. Circulation 2014 ; 130(15): 1245–1253. doi:10.1161/CIRCULATIONAHA.114.011590. 

Novel insights of dietary polyphenols and obesity (01/2014). Referencia:  Wang S, Moustaid-Moussa N, Chen L, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem 2014 January ; 25(1): 1–18. doi:10.1016/j.jnutbio.2013.09.001.

Circulating and dietary omega-3 and omega-6 polyunsaturated fatty acids and incidence of CVD in the Multi-Ethnic Study of Atherosclerosis (12/2013). Referencia: de Oliveira Otto MC, Wu JH, Baylin A, et al. Circulating and Dietary Omega-3 and Omega-6 Polyunsaturated Fatty Acids and Incidence of CVD in the Multi-Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 2013; 2(6): e000506. doi:  10.1161/JAHA.113.000506 .

Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials (04/2013). He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325. doi: http://dx.doi.org/10.1136/bmj.f1325.

Effects of Brazilian Cardioprotective Diet Program on risk factors in patients with coronary heart disease: a Brazilian Cardioprotective Diet randomized pilot trial (12/2012). Referencia: Weber B, Galante AP, Bersch-Ferreira AC, et al. Effects of Brazilian Cardioprotective Diet Program on risk factors in patients with coronary heart disease: a Brazilian Cardioprotective Diet randomized pilot trial. CLINICS 2012;67(12):1407-1414. doi:  10.6061/clinics/2012(12)10.

Ejercicio 

Comparing the Effects of Rest and Massage on Return to Homeostasis Following Submaximal Aerobic Exercise: a Case Study (03/2016). Referencia: Resnick PB. Comparing the Effects of Rest and Massage on Return to Homeostasis Following Submaximal Aerobic Exercise: a Case Study. International Journal of Therapeutic Massage and Bodywork 2016; 9(1): 4–10.

The cardiovascular response to passive movement is joint dependent (03/2016). Referencia: Burns KJ, Pollock BS, McDaniel J. The cardiovascular response to passive movement is joint dependent. Physiological Reports 2016; 4: e12721. DOI: 10.14814/phy2.12721.

Association between baseline cardiovascular mechanics and exercise capacity in patients with coronary artery disease (11/2015). Referencia: Aslanger E, Assous B, et al. Association between baseline cardiovascular mechanics and exercise capacity in patients with coronary artery disease. Anatol J Cardiol 2016; 16: 000-000. DOI:10.5152/AnatolJCardiol.2015.6471.

Effect of Cardiac Rehabilitation Program on Heart Rate Recovery in Coronary Heart Disease (10/2015). Referencia: Mahdavi Anari L, Ghanbari-Firoozabadi M, et al. Effect of Cardiac Rehabilitation Program on Heart Rate Recovery in Coronary Heart Disease. The Journal of Tehran University Heart Center 2015;10(4):176-181.

Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials (10/2015). Referencia: Wang X, Pi Y, et al. Effect of traditional Chinese exercise on the quality of life and depression for chronic diseases: a meta-analysis of randomised trials. Scientific Reports 2015; 5: 15913. doi:  10.1038/srep15913.

Impaired systolic blood pressure recovery and heart rate recovery after graded exercise in patients with metabolic syndrome (01/2015). Referencia: Alihanoglu YI, Yildiz BS, et al. Impaired Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Patients With Metabolic Syndrome. Medicine 2015; 94(2): e428. doi: 10.1097/MD.0000000000000428.

Diabetes Mellitus

Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2 : A Systematic Review and Meta-Analysis (2015). Referencia: Baskota A, Li S, Dhakal N, Liu G, Tian H (2015) Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2 : A Systematic Review and Meta-Analysis. PLoS ONE 10(7): e0132335. doi:10.1371/journal.pone.0132335

A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)Referencia: Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Southampton (UK): NIHR Journals Library; 2015 Jul. (Health Technology Assessment, No. 19.57.) Available from: http://www.ncbi.nlm.nih.gov/books/NBK305602/ doi: 10.3310/hta19570

Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Referencia: Muris DM, Houben AJ, Schram MT, Stehouwer CD. Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):3082-94. doi: 10.1161/ATVBAHA.112.300291. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23042819

Prediabetes Diagnosis and Treatment in Primary Care. Referencia: Mainous AG , Tanner RJ, Baker R. Prediabetes Diagnosis and Treatment in Primary Care. J Am Board Fam Med. 2016 Mar-Apr;29(2):283-5. doi: 10.3122/jabfm.2016.02.150252. Sitio web: http://www.ncbi.nlm.nih.gov/pubmed/26957387

Treatment of prediabetes. Referencia: Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World Journal of Diabetes. 2015;6(12):1207-1222. doi:10.4239/wjd.v6.i12.1207. Sitio web: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598604/

Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. Referencia: Manivel R, Ravanan P, Meenakshisundram C, et al. Study to Predict Vascular Dysfunctions in High Risk Young Adults- An Immediate Non-Invasive Investigation to Prevent Early Vascular Ageing. Journal of Clinical and Diagnostic Research : JCDR. 2015;9(7):CC01-CC03. doi:10.7860/JCDR/2015/12358.6146.

Statin use in prediabetic patients: rationale and results to date. Referencia: Kei A, Rizos EC, Elisaf M. Statin use in prediabetic patients: rationale and results to date. Therapeutic Advances in Chronic Disease. 2015;6(5):246-251. doi:10.1177/2040622315596118. Sitio web: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549696/

Hipertensión

Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data (01/2016). Referencia: Choi SI , Kim SK, et al. Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data. Clinical Hypertension 2016; 22:8. DOI 10.1186/s40885-016-0045-x.

High-Dose versus Low-Dose Vitamin D Supplementation and Arterial Stiffness among Individuals with Prehypertension and Vitamin D Deficiency (09/2015). Referencia: Zaleski A, Panza G, et al. High-Dose versus Low-Dose Vitamin D Supplementation and Arterial Stiffness among Individuals with Prehypertension and Vitamin D Deficiency. Disease Markers 2015; 2015: 918968. doi:  10.1155/2015/918968.

Detecting masked high blood pressure in high-risk patients (08/2015). Referencia: Kim H. Detecting masked high blood pressure in high-risk patients. Korean J Intern Med. 2015 Sep; 30(5): 590–592. doi:  10.3904/kjim.2015.30.5.590.

Clinical Value of Ambulatory Blood Pressure: evidence and limits (03/2015).  Referencia: Mancia G, Verdecchia P, et al. Clinical value of ambulatory blood pressure: evidence and limits. Circulation Research  2015 ;116(6):1034-45. doi: 10.1161/CIRCRESAHA.116.303755.

Screening for High Blood Pressure in Adults (12/2014). Referencia: Piper MA, Evans CV, MPP, Burda BU, et al. Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality (US) 2014; Report No.: 13-05194-EF-1. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0072081/.

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3 (09/2014). Referencia: Bakris GL, Townsend RR, et al. Impact of Renal Denervation on 24-Hour Ambulatory Blood Pressure: Results From SYMPLICITY HTN-3. JACC 2014; 64: 11: 1071-1078. doi:10.1016/j.jacc.2014.05.012.

Pharmacological interventions for hypertension in children (09/2014). Referencia: Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R. Pharmacological interventions for hypertension in children. Evid Based Child Health 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974.

A controlled trial of renal denervation for resistant hypertension (04/2014).  Referencia: Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, et al. A controlled trial of renal denervation for resistant hypertension. New England Journal of Medicine 2014;370(15):1393-401. doi: 10.1056/NEJMoa1402670.

High prevalence of masked uncontrolled hypertension in people with treated hypertension (02/2014). Referencia: Banegas JR, Ruilope LM, et al. High prevalence of masked uncontrolled hypertension in people with treated hypertension. European Heart Journal 2014; 35:3304–3312 DOI: http://dx.doi.org/10.1093/eurheartj/ehu016 3304-3312.

Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome (01/2014).  Referencia: Stergiou GS, Asayama K, et al. Prognosis of White-Coat and Masked Hypertension: International Database of Home Blood Pressure in Relation to Cardiovascular Outcome. Hypertension 2014; 63: 675-682. doi: 10.1161/HYPERTENSIONAHA.113.02741

Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence (11/2013). Referencia: Grigoryan L, Pavlik VN, et al. Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence. J Am Soc Hypertens 2013; 7(6):. doi10.1016/j.jash.2013.06.004.

Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension (01/2012).  Referencia: Muxfeldt ES, Fiszman R, et al. Appropriate Time Interval to Repeat Ambulatory Blood Pressure Monitoring in Patients With White-Coat Resistant Hypertension. Hypertension 2012; 59: 384-389. doi: 10.1161/HYPERTENSIONAHA.111.185405.

Dislipidemias

Lipids in liver transplant recipients. Referencia: Hüsing A, Kabar I, Schmidt HH. Lipids in liver transplant recipients. World J Gastroenterol 2016; 22(12): 3315-3324 Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i12/3315.htm DOI: http://dx.doi.org/10.3748/wjg.v22. i12.3315. Sitio web: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806189/

Nonalcoholic fatty liver disease: Synopsis of current developments. Referencia: Onyekwere C A, Ogbera A O, Samaila A A, Balogun B O, Abdulkareem F B. Nonalcoholic fatty liver disease: Synopsis of current developments. Niger J Clin Pract [serial online] 2015 [cited 2016 May 5];18:703-12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26289505

 

*Hacer Click: Guías de manejo clínico.